Question 1

Which countries lead NF-κB Signaling Pathways research?

Accepted Answer

By volume, China and the United States publish the most (1.2k and 359 works in 2022-now).

Question 2

Which institutions lead NF-κB Signaling Pathways research?

Accepted Answer

By volume in 2022-now, Nanjing Medical University publishes the most NF-κB Signaling Pathways research, followed by Shanghai Jiao Tong University and Zhejiang University.

Question 3

Who are the leading researchers in NF-κB Signaling Pathways?

Accepted Answer

The most-cited researchers publishing on NF-κB Signaling Pathways include Eric S. Lander, Mark J. Daly and Guido Kroemer.

Question 4

Where is NF-κB Signaling Pathways research done?

Accepted Answer

The largest centres of NF-κB Signaling Pathways research in 2022-now are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Wenzhou.

Question 5

Where is the best place to study NF-κB Signaling Pathways?

Accepted Answer

Among universities, judged by research, Sun Yat-sen University, Zhejiang University and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Question 6

Is NF-κB Signaling Pathways research growing?

Accepted Answer

Output in 2022-2025 was 21% lower than in 2018-2021, peaking in 2010.

Question 7

What are the most cited papers in NF-κB Signaling Pathways?

Accepted Answer

The most cited paper in NF-κB Signaling Pathways is "NF-κB signaling in inflammation" (Ting Liu, Lingyun Zhang, Donghyun Joo et al., 2017), with 8,517 citations. Next come "Toll-Like Receptors" (6,179) and "Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death" (6,042).